Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Bicarbonate for Prevention of Contrast-Induced Nephropathy in Emergent Coronary Procedures
NCT00700375Phase 4Completed
- Sponsor
- Osaka General Medical Center
- Start
- Jul 2008
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sodium bicarbonate in contrast-induced nephropathy (CIN), sponsored by Osaka General Medical Center. Started Jul 2008; status: completed.
02
Drugs
sodium bicarbonate
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on NCT00700375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00700375.